Swiss brand has been acquired by a brand in China.

In just two years from 215 to 216, the Swiss brand was acquired by a brand in China. Now, Swiss products are not only available in Australia, but also in major countries and cities in Europe, Asia and Latin America.

Establish an agency model in China, and settle in major e-commerce platforms, so that Swisse brand products can be bought through more channels, so that Chinese people do not have to go overseas to buy health care products.

Synbiotics maintains Swisse's independent operation mode, and Swisse's headquarters and manufacturers have not moved out of Australia to China for this reason, ensuring that Swisse is 1% Australian in the eyes of China consumers.

Extended information:

Acquisition event:

In September 215, Synbiotics International Holdings Limited (referred to as Synbiotics) defeated Shanghai Pharmaceutical Group and Hony Capital, and acquired Swisse)83% Wellness Pty, a famous Australian health care brand, for 1.67 billion Australian dollars (about 7.6 billion RMB at that time).

The second acquisition was in December 216, and Synbiotics acquired the remaining 17% shares of Swisse for A $333 million (then about RMB 1.59 billion).

Synbiotics, whose full name is Guangzhou Synbiotics Biological Products Co., Ltd., is a high-end infant nutrition brand in China. It was established in 1999 and listed in Hongkong in 21 (stock code: 1112).